Intergroupe francophone de cancérologie thoracique, Société de pneumologie de langue française, and Société d'imagerie thoracique statement paper on lung cancer screening.
Early detection of cancer
Lung neoplasm
Multi-detector computed tomography
Multiple pulmonary nodules
Solitary pulmonary nodule
Journal
Diagnostic and interventional imaging
ISSN: 2211-5684
Titre abrégé: Diagn Interv Imaging
Pays: France
ID NLM: 101568499
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
22
04
2020
revised:
21
01
2021
accepted:
29
01
2021
pubmed:
3
3
2021
medline:
19
8
2021
entrez:
2
3
2021
Statut:
ppublish
Résumé
Following the American National Lung Screening Trial results in 2011 a consortium of French experts met to edit a statement. Recent results of other randomized trials gave the opportunity for our group to meet again in order to edit updated guidelines. After literature review, we provide here a new update on lung cancer screening in France. Notably, in accordance with all international guidelines, the experts renew their recommendation in favor of individual screening for lung cancer in France as per the conditions laid out in this document. In addition, the experts recommend the very rapid organization and funding of prospective studies, which, if conclusive, will enable the deployment of lung cancer screening organized at the national level.
Identifiants
pubmed: 33648872
pii: S2211-5684(21)00033-4
doi: 10.1016/j.diii.2021.01.012
pii:
doi:
Types de publication
Practice Guideline
Langues
eng
Sous-ensembles de citation
IM
Pagination
199-211Informations de copyright
Copyright © 2021. Published by Elsevier Masson SAS.